Elos Medtech Logo

Elos Medtech

ISIN

SE0000120776

Ticker

ELOS

Sector

Health Care

Sub-Industry

Health Care Technology

Country

Sweden

Year Founded

1923

About Elos Medtech

Company Description

We are a committed global solution partner that leverages our capabilities in the U.S., Europe, and China – offering Complete Performance™ and vertical integration to leading medical device companies worldwide.

Our success in the medtech industry starts with our people.
The success of Elos Medtech starts with our people, experts in their respective fields with an uncompromising focus on quality, who listen to your needs and systematically apply our knowledge to develop creative solutions that keep our customers poised for success today and in the future.

A partner who goes above and beyond to meet customer needs.
Medical technologies and markets change very quickly. This makes foresight, flexibility, responsiveness, and meticulous attention to detail are absolutely essential.

Served Area

Worldwide

Headquarters

Torsgatan 5B
41104, Göteborg
Sweden

Financial statements

Download as Excel
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 1,002,035,000.00 1,126,397,000.00 1,422,908,000.00
Noncurrent Assets N/A 667,350,000.00 743,316,000.00 872,101,000.00
Property Plant And Equipment N/A 412,242,000.00 469,537,000.00 562,386,000.00
Land And Buildings N/A 173,883,000.00 210,747,000.00 243,788,000.00
Machinery N/A 144,823,000.00 196,438,000.00 248,999,000.00
Fixtures And Fittings N/A 12,571,000.00 16,828,000.00 15,855,000.00
Construction In Progress N/A 34,917,000.00 12,542,000.00 23,906,000.00
Goodwill N/A 234,869,000.00 255,241,000.00 290,782,000.00
Other Intangible Assets N/A 11,206,000.00 9,517,000.00 5,846,000.00
Other Noncurrent Receivables N/A 433,000.00 663,000.00 0.00
Deferred Tax Assets N/A 903,000.00 751,000.00 126,000.00
Noncurrent Investments Other Than Investments Accounted For Using Equity Method N/A 17,000.00 17,000.00 17,000.00
Current Assets N/A 334,685,000.00 383,081,000.00 550,807,000.00
Inventories N/A 158,189,000.00 172,500,000.00 230,389,000.00
Raw Materials N/A 42,438,000.00 50,888,000.00 63,777,000.00
Work In Progress N/A 43,681,000.00 54,671,000.00 62,234,000.00
Finished Goods N/A 72,070,000.00 66,941,000.00 104,378,000.00
Trade And Other Current Receivables N/A 88,043,000.00 115,449,000.00 151,696,000.00
Other Current Receivables N/A 3,878,000.00 4,263,000.00 6,135,000.00
Current Tax Assets Current N/A 3,118,000.00 5,452,000.00 5,698,000.00
Cash and cash equivalents 55,172,000.00 88,453,000.00 95,132,000.00 168,722,000.00
Current Prepayments And Other Current Assets N/A N/A 9,156,000.00 17,626,000.00
Equity And Liabilities N/A 1,002,035,000.00 1,126,397,000.00 1,422,908,000.00
Equity 539,911,000.00 540,298,000.00 634,432,000.00 798,485,000.00
Issued Capital N/A 50,425,000.00 50,425,000.00 50,425,000.00
Retained Earnings N/A 343,562,000.00 404,273,000.00 500,613,000.00
Share Premium N/A 145,511,000.00 145,511,000.00 145,511,000.00
Other Reserves N/A 800,000.00 34,223,000.00 101,936,000.00
Noncurrent Liabilities N/A 305,338,000.00 316,618,000.00 468,997,000.00
Noncurrent Provisions For Employee Benefits N/A 63,508,000.00 70,525,000.00 45,773,000.00
Deferred Tax Liabilities N/A 19,725,000.00 28,938,000.00 46,291,000.00
Longterm Borrowings N/A 222,105,000.00 217,155,000.00 376,933,000.00
Current Liabilities N/A 156,399,000.00 175,347,000.00 155,426,000.00
Trade And Other Current Payables N/A 35,505,000.00 40,979,000.00 43,850,000.00
Accruals Classified As Current N/A 45,233,000.00 49,750,000.00 62,911,000.00
Other Current Payables N/A 22,468,000.00 13,389,000.00 7,482,000.00
Current Tax Liabilities Current N/A 1,914,000.00 1,885,000.00 17,639,000.00
Line item in (sek) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue 580,000,000.00 723,581,000.00 888,542,000.00
Other Income 2,021,000.00 4,259,000.00 4,147,000.00
Profit Loss From Operating Activities 63,617,000.00 101,091,000.00 122,396,000.00
Finance Income 366,000.00 7,835,000.00 11,877,000.00
Finance Costs 20,723,000.00 10,902,000.00 35,170,000.00
Profit Loss Before Tax 43,260,000.00 98,024,000.00 99,103,000.00
Income Tax Expense Continuing Operations 7,228,000.00 22,434,000.00 24,053,000.00
Profit (loss) 36,032,000.00 75,590,000.00 75,050,000.00
Profit Loss Attributable To Owners Of Parent 36,032,000.00 75,590,000.00 75,050,000.00
Line item in (sek) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A 36,032,000.00 75,590,000.00 75,050,000.00
Adjustments For Decrease Increase In Inventories N/A 8,610,000.00 -7,253,000.00 -41,583,000.00
Adjustments For Depreciation And Amortisation Expense N/A 60,035,000.00 55,489,000.00 66,791,000.00
Other Adjustments For Noncash Items N/A 11,252,000.00 -2,093,000.00 8,591,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 10,596,000.00 18,242,000.00 11,526,000.00
Cash Flows From Used In Operating Activities N/A 125,560,000.00 104,975,000.00 108,278,000.00
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities N/A 511,000.00 122,000.00 0.00
Purchase Of Other Longterm Assets Classified As Investing Activities N/A 266,000.00 0.00 N/A
Cash Flows From Used In Investing Activities N/A -56,285,000.00 -85,438,000.00 -117,231,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 42,931,000.00 60,894,000.00 343,564,000.00
Repayments Of Borrowings Classified As Financing Activities N/A 73,410,000.00 67,799,000.00 269,563,000.00
Dividends Paid Classified As Financing Activities N/A 0.00 12,102,000.00 0.00
Cash Flows From Used In Financing Activities N/A -31,320,000.00 -19,007,000.00 74,001,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes N/A 37,955,000.00 530,000.00 65,048,000.00
Effect Of Exchange Rate Changes On Cash And Cash Equivalents N/A -4,674,000.00 6,149,000.00 8,542,000.00
Cash and cash equivalents 55,172,000.00 88,453,000.00 95,132,000.00 168,722,000.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2022 - Q4 Swedish 🇸🇪 Published: 09.05.2023
  • Consolidated Report 2021 - Q4 Swedish 🇸🇪

Insider Trades

Date Trading entity / Person Association Trade type Volume
16.11.2022 Ewa Linsäter Other Sell SEK 327,332.00
16.11.2022 Ewa Linsäter Other Sell SEK 293.00
15.11.2022 Ewa Linsäter Other Sell SEK 146,000.00
10.12.2021 Ewa Linsäter Other Sell SEK 45,600.00
10.12.2021 Ewa Linsäter Other Sell SEK 38,125.00
10.12.2021 Ewa Linsäter Other Sell SEK 30,600.00
10.12.2021 Ewa Linsäter Other Sell SEK 28,272.00
10.12.2021 Ewa Linsäter Other Sell SEK 13,680.00
10.12.2021 Ewa Linsäter Other Sell SEK 1,540.00
08.12.2021 Ewa Linsäter Other Sell SEK 1,260.00

Capital Markets Information

ISIN

SE0000120776

LEI

529900I5MSNU451FL670

Listed Stock Exchange

Nasdaq Stockholm

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.